Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/TP53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Mauro, FR (author)

Tedeschi, A (author)

Piciocchi, A (author)

show more...

Motta, M (author)

Iannella, E (author)

Farina, L (author)

Scarfo, L (author)

Marasca, R (author)

Coscia, M (author)

Cortelezzi, A (author)

Laurenti, L (author)

Melpignano, A (author)

Zinzani, PL (author)

Molica, S (author)

Re, F (author)

Andriani, A (author)

Vincelli, DI (author)

Visco, C (author)

Gozzetti, A (author)

Orlandi, EM (author)

Trentin, L (author)

Tani, M (author)

Califano, C (author)

Tagariello, G (author)

Ghia, P (author)

Caputo, MD (author)

Salaroli, A (author)

Innocenti, I (author)

Frustaci, A (author)

Vitale, C (author)

Petulla, M (author)

de Fabritiis, P (author)

Vignetti, M (author)

Fazi, P (author)

Foa, R (author)

show less...

2016

2016

English.

In: BLOOD. - 0006-4971. ; 128:22

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Conference paper (other academic/artistic)